Results of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC)

被引：0

作者：

Westeel, V. ^{[1
]}

Barlesi, F. ^{[2
]}

Foucher, P. ^{[3
]}

Lafitte, J-J. ^{[4
]}

Domas, J. ^{[5
]}

Girard, P. ^{[6
]}

Tredaniel, J. ^{[7
]}

Wislez, M. ^{[8
]}

Dumont, P. ^{[9
]}

Quoix, E. ^{[10
]}

Raffy, O. ^{[11
]}

Braun, D. ^{[12
]}

Derollez, M. ^{[13
]}

Goupil, F. ^{[14
]}

Hermann, J. ^{[15
]}

Devin, E. ^{[16
]}

Pichon, E. ^{[17
]}

Gury, J-P. ^{[18
]}

Morin, F. ^{[19
]}

Souquet, P-J. ^{[20
]}

机构：

[1] Hop Jean Minjoz, CHRU Besancon, Pneumol, Besancon, France

[2] Aix Marseille Univ, AP HM, Multidisciplinary Oncol & Therapeut Innovat, Marseille, France

[3] CHU Le Bocage Dijon, Pneumol, Dijon, France

[4] CHRU Lille, Hop Calmette, Pneumol, Lille, France

[5] Ctr Catalan Oncol Clin St Pierre, Pneumol, Perpignan, France

[6] Inst Mutualiste Montsouris, Pneumol, Paris, France

[7] Hop St Joseph, Pneumol, Paris, France

[8] Tenon Univ Hosp, AP HP, Pneumol, CancerEst, Paris, France

[9] Ctr Hosp, Pneumol, Chauny, France

[10] CHU Strasbourg, Serv Pneumol, Pole Pathol Thorac, NHC, Strasbourg, France

[11] Ctr Hosp, Pneumol, Chartres, France

[12] Cabinet, Pneumol, Briey, France

[13] Clin Val de Sambre, Pneumol, Maubeuge, France

[14] Ctr Hosp, Pneumol, Le Mans, France

[15] HPMetz Hop Robert Schuman, Pneumol, Metz, France

[16] CHI EureSeine Evreux, Pneumol, Evreux, France

[17] CHRU Bretonneau, Pneumol, Tours, France

[18] Ctr Hosp, Pneumol, Vesoul, France

[19] French Cooperat Thorac Intergrp, Clin Res Unit, Paris, France

[20] Ctr Hosp Lyon Sud, Pneumol, Pierre Benite, France

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1273O

引用

页数：1

共 50 条

[21] A small randomized phase III single-center trial on postoperative UFT administration in patients with completely resected non-small cell lung cancer
Ueda, H
Sakada, T
Kuwahara, M
Motohiro, A
ANTI-CANCER DRUGS, 2004, 15 (01) : 29 - 33
[22] CANOPY-A: Phase III study of canakinumab (CAN) as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC)
Garon, E. B.
Lu, S.
Goto, Y.
De Marchi, P. R.
Paz-Ares, L.
Spigel, D. R.
Thomas, M.
Yang, J. C-H.
Ardizzoni, A.
Barlesi, F.
Khanna, S.
Bossen, C.
Carbini, M.
Yovine, A.
Cho, B. C.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1414 - S1415
[23] A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in Japan
Yukito Ichinose
Cancer Chemotherapy and Pharmacology, 2006, 58 : 43 - 48
[24] A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in Japan
Ichinose, Yukito
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (Suppl 1) : S43 - S48
[25] Updated survival analysis of JBR.10: A randomized phase III trial of vinorelbine/cisplatin versus observation in completely resected stage IB and II non-small cell lung cancer (NSCLC)
Vincent, M. D.
Butts, C.
Seymour, L.
Ding, K.
Graham, B.
Twumasi-Ankrah, P.
Gandara, D.
Schiller, J.
Green, M.
Shepherd, F.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[26] Phase II Study of Nimotuzumab plus Concurrent Chemoradiotherapy (CRT) for Stage III Non-Small Cell Lung Cancer (NSCLC): 5-Year Follow-Up Results
Hayakawa, Kazushige
Nishimura, Yasumasa
Harada, Hideyuki
Soejima, Toshinori
Tsujino, Kayoko
Kozuka, Takuyo
Tanaka, Masahiro
Sasaki, Tomonari
Yamamoto, Nobuyuki
Nakagawa, Kazuhiko
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S375 - S376
[27] Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE Trial
Matsubara, Taichi
Yamaguchi, Masafumi
Shimokawa, Mototsugu
Okamoto, Isamu
CLINICAL LUNG CANCER, 2024, 25 (03) : 280 - 283
[28] Neoadjuvant combined treatment for stage III non-small cell lung cancer (NSCLC): Results of a prospective phase II trial
Thomas, M
Rube, C
Semik, M
Klinke, F
VonEiff, M
VandeLoo, J
2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 431 - 433
[29] Phase III study comparing preoperative and perioperative chemotherapy (CT) with two different regimens in resectable non-small cell lung cancer (NSCLC): the results of the IFCT-0002 study
Quoix, Elisabeth
Lavole, Armelle
Westeel, Virginie
Puyraveau, Marc
Bigay-Game, Laurence
Ozenne, Gervais
Gervais, Radj
Lebeau, Bernard
Debieuvre, Didier
Poudenx, Michel
David, Philippe
Morin, Franck
Cadranel, Jacques
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S330 - S331
[30] Results of the Randomized International Adjuvant Lung Cancer Trial (IALT): Cisplatin-based chemotherapy (CT) vs no CT in 1867 patients (pts) with resected non-small cell lung cancer (NSCLC).
Le Chevalier, T
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 238S - 238S

← 1 2 3 4 5 →